company background image
1332 logo

Touyun Biotech Group SEHK:1332 Stock Report

Last Price

HK$0.19

Market Cap

HK$544.4m

7D

10.9%

1Y

-19.8%

Updated

24 Dec, 2024

Data

Company Financials

Touyun Biotech Group Limited

SEHK:1332 Stock Report

Market Cap: HK$544.4m

1332 Stock Overview

An investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. More details

1332 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Touyun Biotech Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Touyun Biotech Group
Historical stock prices
Current Share PriceHK$0.19
52 Week HighHK$0.35
52 Week LowHK$0.13
Beta-0.91
1 Month Change14.12%
3 Month Change14.12%
1 Year Change-19.83%
3 Year Change-84.84%
5 Year Change-13.78%
Change since IPO-14.61%

Recent News & Updates

Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Sep 15
Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Recent updates

Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Sep 15
Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jul 17
Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Apr 22
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

Apr 08
Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Feb 07
What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Dec 18
Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Sep 19
Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Jul 28
Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Sep 13
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

May 18
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Dec 24
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

Mar 12
Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

Jan 15
If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Dec 11
How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Shareholder Returns

1332HK PackagingHK Market
7D10.9%1.9%0.8%
1Y-19.8%-12.5%21.1%

Return vs Industry: 1332 underperformed the Hong Kong Packaging industry which returned -12.5% over the past year.

Return vs Market: 1332 underperformed the Hong Kong Market which returned 21.1% over the past year.

Price Volatility

Is 1332's price volatile compared to industry and market?
1332 volatility
1332 Average Weekly Movement7.4%
Packaging Industry Average Movement5.9%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 1332 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1332's weekly volatility has decreased from 14% to 7% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989526Amy Hatouyunbiotech.com.hk

Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. It operates through four segments: QR Code Business, Packaging Products Business, Treasury Investment Business, and Chlamydomonas Reinhardtii Products Business. The QR Code Business segment provides QR codes on product packaging and solutions, including made-to-order solutions.

Touyun Biotech Group Limited Fundamentals Summary

How do Touyun Biotech Group's earnings and revenue compare to its market cap?
1332 fundamental statistics
Market capHK$544.35m
Earnings (TTM)-HK$232.96m
Revenue (TTM)HK$169.54m

3.2x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1332 income statement (TTM)
RevenueHK$169.54m
Cost of RevenueHK$118.29m
Gross ProfitHK$51.25m
Other ExpensesHK$284.21m
Earnings-HK$232.96m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.083
Gross Margin30.23%
Net Profit Margin-137.41%
Debt/Equity Ratio-1,443.6%

How did 1332 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 20:05
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Touyun Biotech Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution